Infection | Consideration | |
---|---|---|
Chlamydia | Consider self-collection of samples for testing. | |
Gonorrhoea | Consider self-collection of samples for testing. If NAAT test result is positive, take swab at relevant site(s) for culture, before treatment. Cultures are the preferred test for samples from non-genital sites. |
|
Syphilis | If clinical suspicion of syphilis, refer to the syphilis guideline. | |
HIV | HIV status should be confirmed in anyone reporting a history of injecting drugs. Annual testing in those with an ongoing history of injecting drugs is recommended. Repeat test if patient exposed within previous 12 weeks (window period). |
|
Hepatitis A | Vaccinate if not immune. | |
Hepatitis B | PWID are at high risk of hepatitis B acquisition, if not vaccinated and have not been previously exposed to the virus. Vaccinate if not immune. Serological testing after completing vaccination is recommended. |
|
Hepatitis C | Hepatitis C status should be confirmed in all people reporting a history of injecting drugs. Annual testing in those with an ongoing history of injecting drugs is recommended. Hepatitis C is not considered an STI except between HIV infected men having unprotected anal sex. If antibody positive, test for hepatitis C NAAT to determine if patient has chronic hepatitis C. |
|
NAAT – Nucleic Acid Amplification Test |
If test results are positive, refer to STI management section for advice on:
Even if all test results are negative, use the opportunity to: